Singapore Institute of Advanced Medicine (SGX:9G2) expects to post a "significant" net loss after tax for the year ended June 30, according to a filing with the Singapore Exchange on Wednesday.
The group attributes its outlook to the slower-than-expected development and expansion of business operations, which may result in an impairment to its assets, the filing said.
The company is expected to release its financial figures on or before Aug. 29.
Shares of the healthcare company plunged over 19% in recent Thursday trade.
Price (SGD): S$0.09, Change: S$-0.02, Percent Change: -19.13%
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments